End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
191,100 KRW | +0.42% | +8.46% | -5.16% |
Jun. 07 | Celltrion's Avastin Biosimilar Gains 12% Market Share in Japan | MT |
Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.16% | 28.54B | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B | |
-9.14% | 11.06B |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Celltrion's Autoimmune Disease Treatment Hits US Markets